Description
A study of the content of asymmetric dimethylarginine in the blood – an analysis using a modern high-precision method (high-performance liquid chromatography), used to assess the degree of risk of a patient developing cardiovascular complications.
Period of execution
Within 5 days. The specified time does not include the day of biomaterial collection
Biomaterial type